Johnson & Johnson Snags Animas To Advance Artificial Pancreas Design

Johnson & Johnson/LifeScan will acquire long-sought access to the continuous glucose monitoring system (CGMS) market with its $518 mil. purchase of Animas, the firm announced Dec. 16